Innovation Sourcing & Licensing

Innovation Sourcing
Innovation sourcing has become critically important in the healthcare industry, and the interaction between biopharma, academia and small companies is crucial. At BGM, we facilitate the deals between these stakeholders and continuously support our clients in innovation sourcing.

​Licensing
We facilitate the licensing deals between European and Asian companies, bringing innovation across the markets.
We support the leading Korean nuclear medicine company - DuChemBio (DCB) - to expand its  product portfolio in oncology and neurology. Recently, DCB licensed a novel radiopharmaceutical for prostate cancer diagnosis from a leading Japanese nuclear medicine player - Nihon Medi-Physics. DCB effectively became the pioneer on the market in introducing the innovative diagnostic tools for prostate cancer imaging, significantly improving the prostate cancer diagnostic options ofr the Korean patients.